Aberrant Mineralization of Connective Tissues in a Mouse Model of Pseudoxanthoma Elasticum: Systemic and Local Regulatory Factors  by Jiang, Qiujie et al.
Aberrant Mineralization of Connective Tissues in a
Mouse Model of Pseudoxanthoma Elasticum:
Systemic and Local Regulatory Factors
Qiujie Jiang1, Qiaoli Li1 and Jouni Uitto1,2
Pseudoxanthoma elasticum (PXE) is caused by mutations in the ABCC6 gene, but the cellular and molecular
events leading to aberrant mineralization of soft tissues are unknown. To characterize the mineralization
process, we examined a PXE animal model, the Abcc6/ mouse, with respect to specific proteins serving as
inhibitors of mineralization. The levels of calcium and phosphate in serum of these mice were normal, but the
Abcc6/ serum had less ability to prevent the mineral deposition induced by inorganic phosphate in a cell
culture system. Addition of fetuin-A to the culture system prevented the mineralization. The calcium 
phosphate product was markedly elevated in the mineralized vibrissae of Abcc6/mice, an early biomarker of
the mineralization process, consistent with histopathologic findings. Levels of fetuin-A were slightly decreased
in Abcc6/ serum, and positive immunostaining for matrix-gla-protein (MGP), fetuin-A, and ankylosis protein
(Ank) as well as alkaline phosphatase activity were strongly associated with the mineralization process. In situ
hybridization demonstrated that the genes for MGP and Ank were expressed locally in vibrissae, whereas
fetuin-A was expressed highly in the liver. These data suggest that the deposition of the bone-associated
proteins spatially coincides with mineralization and actively regulates this process locally and systemically.
Journal of Investigative Dermatology (2007) 127, 1392–1402. doi:10.1038/sj.jid.5700729; published online 1 February 2007
INTRODUCTION
Pseudoxanthoma elasticum (PXE) is an autosomal recessively
inherited disorder characterized by progressive mineraliza-
tion of the connective tissues primarily within the dermis of
the skin, Bruch’s membrane in the retina, and the mid-layers
of the arterial vessel wall. A characteristic histopathologic
finding in PXE is accumulation of pleiomorphic elastic
structures which become progressively mineralized (Neldner,
1988). Thus, PXE was initially thought to be a prototypic
example of primary heritable connective tissue diseases with
putative mutations in the genes encoding the structural
components of the elastic fiber system (Uitto et al., 1998).
This notion was later proven incorrect, however, by exclu-
sion of the candidate genes associated with the elastic
structures by genetic linkage analyses and by subsequent
demonstrations of mutations in the ABCC6 gene (Bergen
et al., 2000; Le Saux et al., 2000; Ringpfeil et al., 2000; Struk
et al., 2000). The latter gene encodes multidrug resistance-
associated protein 6, a member of the ATP binding cassette
family C, a group of proteins which serve as transmembrane
transporters, often associated with multidrug resistance
(Belinsky and Kruh, 1999; Kool et al.,1999; Belinsky et al.,
2002). To date, the mutant alleles of the ABCC6 gene have
been identified in over 300 families with PXE, and no
evidence for another primary mutant gene has been
implicated, although considerable intra- and inter-familial
heterogeneity noted in this disease suggests the contribution
of modifier genes (Ringpfeil et al., 2001; Chassaing et al.,
2005; Miksch et al., 2005; Pfendner E, Terry SF, Vourthis S,
McAndrew P, McClain MR, Fratta S et al. (2007) Mutation
detection in the ABCC6 gene and analysis in a large
international case series affected by pseudoxanthoma elasti-
cum (submitted)).
Recently, mouse models for PXE have been created by
targeted disruption of Abcc6, which in mutant homozygous
mice results in extensive mineralization of the soft tissues,
including skin, blood vessel walls, and retina, whereas
heterozygous mice are indistinguishable from the wild-type
ones (Gorgels et al., 2005; Klement et al., 2005). Thus, these
mice recapitulate the genetic, histopathologic, and ultra-
structural features of PXE. An intriguing and particularly
striking feature reported in one set of Abcc6/ mice is
mineralization of the connective tissue capsule surrounding
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the bulb of vibrissae, which is detectable at 5–6 weeks of age
and progressively increases, reflecting the aberrant miner-
alization process affecting a number of tissues (Klement et al.,
2005). As mineralization of the connective tissues of the
vibrissae capsule is a prominent and consistent feature in the
Abcc6/ mice, it has been proposed to serve as an early
biomarker of the pathologic process affecting the blood
vessels and the retina. However, the mechanisms leading to
mineralization of connective tissues in the skin, eyes, and the
cardiovascular system as a result of mutations in the ABCC6
gene, which is expressed primarily in the liver and the
kidneys, are unclear.
The function of multidrug resistance-associated protein 6
is currently unknown, but is has been postulated to serve as a
metabolic transmembrane transporter. In fact, certain glu-
tathione-conjugated anionic molecules have been shown to
serve as a substrate for this efflux transporter in vitro (Belinsky
et al., 2002; Ilia´s et al., 2002). Furthermore, selected missense
mutations encountered in PXE are able to abolish the ATP-
dependent transport activity of multidrug resistance-asso-
ciated protein 6, as measured in an in vitro system utilizing
Sf9 insect cells (Ilia´s et al., 2002). Clinical observations and
our preliminary characterization of the Abcc6/ mouse
have revealed that PXE is a slowly progressing condition with
delayed onset. Thus, PXE has been postulated to be a
metabolic disease, so that in the absence of functional
ABCC6 activity, the levels of metabolic compounds in the
circulation, which may have affinity for connective tissues
and calcium, are altered (Uitto et al., 2001; Jiang and Uitto,
2006). The perturbed levels of such compounds in the
circulation may also alter the biosynthetic capacity of
resident cells, leading to histopathological and ultrastructural
abnormalities documented in PXE. This proposed mechanism
of mineralization has been designated as the ‘‘metabolic
hypothesis’’. Alternatively, the ‘‘PXE cell hypothesis’’ postu-
lates that absent expression of ABCC6, which is low, barely
detectable, in physiologic situations in resident cells, such as
fibroblasts or smooth muscle cells, may result in local
mineralization as a result of cellular perturbations (Boraldi
et al., 2003).
Recent studies in end-stage renal disease and athero-
sclerosis have demonstrated that vascular calcification is
associated with bone matrix proteins, implying that the
mineral deposition into vascular tissues in these patients is
not simply a passive metastatic process (Moe et al., 2002;
Trion and van der Laarse, 2004; Hruska et al., 2005). At the
same time, a number of bone-associated proteins, including
fetuin-A, matrix-gla-protein (MGP) and ankylosis (Ank), have
been suggested to play a role in prevention of unwanted
mineralization of connective tissue. This notion is based, in
part, on the observations that development of knockout mice
by targeted ablation of these genes results in extensive soft-
tissue mineralization, including the vascular connective
tissues (Jahnen-Dechent et al., 1997; Luo et al., 1997; Wang
et al., 2005).
To test the ‘‘metabolic hypothesis’’ and to determine if
mineralization observed in PXE is an active, cell-mediated
process rather than passive precipitation of calcium and
phosphorus in the setting of deranged mineral metabolism,
perhaps paralleling that observed in atherosclerotic calcifica-
tion, we examined vibrissae in Abcc6/ mice for the
presence or absence of selected proteins associated with
mineralization, and compared serum from Abcc6/ and
Abcc6þ /þ mice regarding their ability to interfere with the
mineralization process in vitro.
RESULTS
Mineralization of vibrissae in Abcc6/ mice
We have recently developed an animal model for PXE by
targeted ablation of the Abcc6 gene (Klement et al., 2005).
The histopathologic characteristic of this mouse model is
aberrant mineralization of connective tissues in a variety of
organs, including the dermis of the skin, Bruch’s membrane
of the retina, and the vessel walls. Thus, this mouse model
recapitulates features of human PXE. A particularly interesting
finding in this mouse model was mineralization of the
connective tissue capsule surrounding the hair follicles in
vibrissae, and we have proposed that this pathologic feature
could serve as an early biomarker of the overall mineraliza-
tion process in PXE (Klement et al., 2005). In this study, we
confirmed the mineralization of the connective tissue capsule
surrounding vibrissae by a special, calcium-specific stain,
Alizarin Red (Figure 1a). Extensive mineralization was noted
in the vibrissae of 6-month-old Abcc6/ mice, whereas
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Figure 1. Mineralization of vibrissae in Abcc6/ mice. Sections of muzzle
skin from mice, 6 months of age, were stained with Alizarin Red. No
mineralization was noted in the (a, right panel) Abcc6þ /þ mice, whereas
profound mineralization, as reflected by red color was found in the (a, left
panel, arrows) Abcc6/ mice. The calcium and phosphate contents were
determined in 3-month-old mice colorimetrically using o-cresolphthalein
complexone and malachite green, respectively. (b) The Ca P product was
normalized by tissue weight and presented as meanþ SD; n¼ 3–7 mice per
group. The differences between the Abcc6/ and the corresponding
Abcc6þ /þ mice were statistically significant (Po0.02) whereas the
difference between the male and female Abcc6/ mice was not significant
(P40.1).
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their age-matched wild-type counterparts did not show any
evidence of such process. We have also extended the
measurements of mineralization by quantitatively determin-
ing the calcium and phosphate contents of the vibrissae of 3-
month-old mice using colorimetric assays based on o-
cresolphthalein complexone and malachite green. The results
indicated that both male and female Abcc6/ mice
demonstrated statistically significant (Po0.02), B5-fold
increase in the calcium phosphate content when normal-
ized to tissue weight (Figure 1b). It should be noted that there
were no gender-based differences in the degree of miner-
alization at this age of Abcc6/ mice (P40.1).
Serum from Abcc6/ mice promotes mineralization of aortic
smooth muscle cell cultures
The mechanisms leading to mineralization of the peripheral
connective tissues as a result of mutations in the ABCC6
gene, which is expressed primarily in the baso-lateral surface
of hepatocytes in the liver and in proximal tubules of kidneys,
are currently unknown (Belinsky and Kruh, 1999; Scheffer
et al., 2002; Matsuzaki et al., 2005; Jiang et al., 2005). One
possibility, so-called ‘‘metabolic hypothesis’’, postulates that
alterations in the levels of critical circulating factors allow
mineral deposition to occur in tissues. In this context, it
should be noted that the calcium and phosphorus levels both
in patients with PXE and in Abcc6/ mice are normal, and
there is no evidence of perturbed parathyroid and/or vitamin
D metabolism (Neldner, 1988; Klement et al., 2005). To test
the possible role of serum factors in tissue mineralization, we
first cultured human aortic smooth muscle cells in a system
that allows mineralization to occur upon addition of
inorganic phosphate (Pi) to the culture medium (Jono et al.,
2000). Specifically, the cells were cultured in DMEM until
B80% confluent, at which point the cultures were placed in
medium containing 10% fetal calf serum or 10% serum
obtained either from Abcc6þ /þ or Abcc6/ mice
(Figure 2). Addition of 2 mM Pi into the culture medium
(þ Pi) resulted in mineral deposition onto the cells in
comparison to control cultures which were continued to be
maintained in media containing 10% serum without addi-
tional Pi (Figure 2a). Quantitation of calcium associated
with the cell layer, using the o-cresolphthalein complexone
method and normalized by the cellular protein content,
revealed that calcium deposition under calcification-indu-
cing conditions (þPi) was increased B10–20-fold in
comparison to their corresponding controls (Pi). More
importantly, the calcium deposition in cultures incubated
with serum from the Abcc6/ mice with the addition of Pi
was B3 times higher than that noted in cultures maintained
in the presence of Abcc6þ /þ mouse serum plus Pi (Figure
2b). These results suggest that the Abcc6/ mice have
alterations in their serum, either an increase or decrease in
the level of a specific factor(s), which either facilitates or is not
capable of counteracting the mineralization process in vitro.
Serum levels of fetuin-A are reduced in Abcc6/ mice
A number of bone-associated proteins have been shown to
play a critical role in mineralization processes. One of them
is fetuin-A, a serum protein that has been suggested to play a
role in preventing aberrant tissue mineralization. To examine
the role of fetuin-A in mineralization of Abcc6/ mouse
tissues, we first determined the serum levels in 6-month-old
Abcc6/ mice and their wild-type counterparts by an
ELISA. The serum levels were extrapolated from a standard
curve constructed with recombinant mouse fetuin-A protein.
Three separate experiments revealed B30% reduction in
fetuin-A levels in serum from Abcc6/mice on the average,
as compared to controls, although there was considerable
variability between the individual mice. Specifically, the
fetuin-A concentrations in the Abcc6þ /þ and Abcc6/
mouse sera were 148.7739.7 and 91.7733.1 ng/ml, respec-
tively (mean7SE) (Figure 3a).
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Figure 2. Effect of Abcc6/ serum on calcium deposition in human aortic
smooth muscle cell culture. (a) Cells were cultured in DMEM, and after
having reached confluence, the cells were incubated either in normal DMEM
medium (Pi; upper panel) or in medium supplemented with Pi (2 mM) (þ Pi;
lower panel) in the presence of either 10% normal fetal calf serum, or 10%
serum from either Abcc6þ /þ or Abcc6/ mice, for up to 2 weeks. The
medium was changed every 3 days. At 2 weeks after calcification induction,
mineral deposition was assessed by phase-contrast light microscopy. Note the
presence of mineral deposits in the lower panels (arrows), however, more
deposits were found in the cultures with Abcc6/ serum (right lower panel).
(b) The calcium content was measured by o-cresolphthalein complexone
method, normalized by cellular protein content, and presented as meanþ SD
(n¼3 cultures per group in two separate experiments). The differences
between the cultures incubated in calcification-inducing medium with added
inorganic phosphate (þ Pi) in comparison to the corresponding control
medium (Pi) are statistically significant; Po0.01. The values in Abcc6/
serum þ Pi vs Abcc6þ /þ serum þ Pi are also statistically different; Po0.01.
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Fetuin-A is expressed abundantly in the liver
Fetuin-A is a complex glycoprotein known to be synthesized
primarily in the liver. We, therefore, examined the spatial
expression of the corresponding gene in liver first at the
messenger RNA (mRNA) level by using in situ hybridization
(ISH). The results showed clear expression of fetuin-A in the
liver of both in Abcc6þ /þ and Abcc6/ mice (Figure 3b).
The expression was further confirmed at the protein level by
immunofluorescence and Western blot analysis (Figure 3c).
These three independent techniques showed clearly detect-
able expression of fetuin-A in the liver both at mRNA and
protein levels, but no quantitative differences were noted
between the liver samples obtained from the Abcc6/ mice
and their wild-type counterparts (Figure 3b, c). These
observations were confirmed by quantitative microarray
assays which demonstrated a 1.093-fold change in Abcc6/
mice over the corresponding wild-type controls (P40.5;
mean of three mice in each group).
Bone-associated proteins localize to mineralized areas in
vibrissae of the Abcc6/ mice
The association of fetuin-A and other bone-associated
proteins, including MGP, Ank, and type I collagen, as well
as alkaline phosphatase (APase), with the calcification
process of Abcc6/ mouse vibrissae was further examined
by immunofluorescence and/or histochemical analyses (Fig-
ure 4) or by semiquantitative RT-PCR (Table 1). Immuno-
fluorescence demonstrated the association of fetuin-A, MGP,
and Ank with the mineral deposits in vibrissae (Figure 4a–c
and e–g), and furthermore, APase activity was clearly
detected in association of the mineralization process (Figure
4h). Immunostaining for type I collagen epitopes further
indicated that this extracellular matrix protein is an abundant
component of the connective tissue capsule subject to
mineralization in Abcc6/ mice (Figure 4d). It should be
noted that the deposition of fetuin-A, MGP, and Ank as well
as the APase activity were largely confined to the areas of
mineralization (Figure 4). In contrast, unmineralized vibrissae
in Abcc6/ mice or those in wild-type mice showed
negative immunofluorescence for fetuin-A, MGP, and Ank
(results not shown). Semiquantitative RT-PCR, using 18S
rRNA as an internal standard, clearly detected the expression
of MGP, Ank, and APase in the skin specimens from the
muzzle, although the level of the latter two mRNAs was low.
Fetuin-A mRNA levels in vibrissae preparations were very
low, barely detectable. No significant differences between
the wild-type and knockout mice were noted (Table 1).
ISH reveals expression of bone-associated proteins in Abcc6/
mouse vibrissae
As the tissue specimens obtained from the mice contain
extracellular matrix and cells not necessarily associated with
the vibrissae, the spatial expression of the bone-associated
genes was further examined by ISH with digoxigenin (Dig)-
labeled cRNA antisense and sense probes. Strong signals
were clearly detected with antisense probes for MGP and for
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Figure 3. Association of fetuin-A with mineralization in Abcc6/ mice. (a) Serum samples were obtained from age- and gender-matched Abcc6/ and
Abcc6þ /þ mice of 6 months of age and analyzed to determine the level of fetuin-A by ELISA, as described in Materials and Methods (n¼ 3; meanþ SE).
A standard curve constructed with recombinant mouse fetuin-A is included in the top and was used for calibration. (b) mRNA expression of fetuin-A in mouse
liver was analyzed by ISH with a Dig-labeled sense and antisense cRNA probes. Positive signal in ISH is indicated by bright red color. (c) Protein expression of
fetuin-A in liver was examined by (left panel) immunofluorescence on frozen sections and by (right panel) Western blot analysis of liver extracts.
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type I collagen, confirming the RT-PCR analyses (Figure 5b vs
g, and c vs h). Positive, yet weaker, signals were observed
with antisense probes for APase and Ank, consistent with the
RT-PCR results (Figure 5, d vs i, and e vs j). In contrast, no
signal was observed with fetuin-A antisense or sense probe
(Figure 5, a vs f ), suggesting that the very low level of fetuin-A
mRNA detected by RT-PCR may reflect its origin from cells
other than those associated with vibrissae. Furthermore, these
observations are consistent with the notion that fetuin-A gene
is primarily expressed in the liver (see Figure 3b and c).
Collectively, our results demonstrate association of a number
of bone-associated gene products with the mineralization
process affecting connective tissue in a mouse model for PXE.
Inhibition of the mineralization process in smooth muscle cell
cultures by recombinant mouse fetuin-A
As indicated above, addition of 2 mM Pi to the medium of
smooth muscle cell cultures, in the presence of serum, is able
to elicit Ca P precipitation. The results further suggested
that Abcc6/ mouse serum had a factor or factors that were
either promoting mineralization or had less capacity to
counteract the Pi-mediated mineralization process. In the
light of the observation that Abcc6/ mouse sera were
deficient in fetuin-A, a potent inhibitor of the mineralization
process, we examined in this cell culture system, which
contains 10% Abcc6/ mouse serum, whether addition of
recombinant mouse fetuin-A might correct such deficiency.
First, smooth muscle cells were cultured up to B80%
confluence, and some cultures then received 2 mM inorganic
phosphate (þ Pi) whereas others were continuously main-
tained without additional phosphate (Pi). As shown in
Figure 6, addition of Pi resulted in extensive mineralization of
the cultures (Figure 6a), and calcium deposition could be
quantitated by the o-cresolphthalein complexone method
(Figure 6b; þPi vs –Pi). Addition of recombinant mouse
fetuin-A, 900 or 1,350 ng to the total volume of 80 ml of
medium (i.e., 11.3 and 16.9 ng/ml, respectively), concomitant
to the addition of Pi prevented the mineralization
process (Figure 6a). The inhibition was essentially complete
with the addition of 1,350 ng of the recombinant protein
(Figure 6b).
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Figure 4. The presence of bone-associated proteins in Abcc6/ mouse calcified vibrissae. (e–g) Paraffin sections of muzzle skin from Abcc6 / mice
were processed and stained by Alizarin Red, and examined by immunofluorescence with antibodies recognizing (a) fetuin-A, (b) MGP, (c) Ank, and (d) type I
collagen epitopes. Frozen sections of vibrissae from Abcc6/ mice were also analyzed histochemically for (h) APase activity. (e–g) The reddish-brown color
(arrows) signifies mineralization, whereas the (h) dark purplish color (arrow) indicates APase activity. The secondary antibody in (a–c) was FITC-conjugated IgG,
whereas that in (d) was Texas Red-conjugated IgG, the signals coinciding with the mineralization of the connective tissue capsule of vibrissae (asterisks).
Table 1. Relative expression of bone-associated
protein mRNAs in vibrissae of Abcc6/ (KO) and
Abcc6+/+ (WT) mice.
Gene1 Mice2 Relative mean density3 Change4
MGP WT 0.7970.24 1.00
KO 0.7670.40 0.96
Ank WT 1.0570.04 1.00
KO 0.9270.10 0.88
APase WT 0.9570.37 1.00
KO 0.8170.24 0.85
Fetuin-A WT 0.8470.15 1.00
KO 0.6970.04 0.82
1Ank, ankylosis; APase, alkaline phosphatase; KO, knockout; mRNA,
messenger RNA; MGP, matrix-gla-protein; WT, wild type.
2n=3 mice per group.
3The values represent the density of the target gene mRNA in relation to
18S internal control co-amplified in the same mRNA preparation and
quantitated from ethidium bromide stained agarose gels by Scion Imaging
Software (Scion Corporation, Frederick, MD) (mean7SD).
4The values indicate the differences of KO mouse relative mean density in
comparison to WT mice set at 1.00.
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DISCUSSION
PXE is an autosomal-recessive disorder characterized by
aberrant mineralization of connective tissues in the skin,
eyes, and the cardiovascular system, leading to considerable
morbidity and mortality (Neldner, 1988; Pfendner E, Terry SF,
Vourthis S, McAndrew P, McClain MR, Fratta S et al. (2007)
Mutation detection in the ABCC6 gene and analysis in a large
international case series affected by pseudoxanthoma elasti-
cum (submitted); Ringpfeil et al., 2006). The diagnostic
hallmark of PXE is the cutaneous findings, the primary lesions
being yellowish dermal papules, which coalesce to form
inelastic, loose, and sagging skin. Although the skin findings
are primarily of cosmetic concern, their presence can signify
mineralization of vascular connective tissues potentially
leading to fragility and bleeding of blood vessels, intermittent
claudication, and occasionally to cardiovascular accidents.
An associated pathologic feature is mineralization of the
Bruch’s membrane in the retina of the eye, clinically leading
to angioid streaks and loss of visual acuity.
PXE is caused by mutations in the ABCC6 gene which is
expressed primarily in the liver and to a lesser extent in the
proximal tubules of the kidneys, and only at very low levels,
if at all, in tissues affected in PXE (Beck et al., 2003;
Matsuzaki et al., 2005). These observations allowed us to
hypothesize early on that PXE may be a metabolic disorder at
the genome–environment interface (Uitto et al., 2001). This
so-called ‘‘metabolic hypothesis’’ proposes a central role for
circulating factors in the mineralization process in PXE (Jiang
and Uitto, 2006). An alternative postulate, the ‘‘PXE cell
hypothesis’’, has been advanced primarily on the basis of
work on fibroblast cultures established from the skin of
patients with PXE. These cells have been suggested to display
abnormalities in cell–cell and cell–matrix adhesion proper-
ties, in the proliferative capacity of the cells harboring the
mutations, and in the rate of synthesis of connective tissue
components, such as elastin, collagen, and proteoglycans
(Boraldi et al., 2003). These cells have also been suggested to
suffer from mild chronic oxidative stress and to demonstrate
increased degradative potential as reflected by elevated
matrix metalloproteinase-2 expression (Quaglino et al.,
2005a, b; Pasquali-Ronchetti et al., 2006). Thus, the ‘‘PXE
cell hypothesis’’ postulates that the basic defect in PXE
resides in the abnormalities of the resident cells in affected
tissues, including fibroblasts in the skin and smooth muscle
cells in vascular connective tissues. The question of the
precise mechanisms of the mineralization process, that is,
generalized and metabolic versus localized and cell specific,
clearly has implications for potential treatment of this
disorder.
Early on, evidence for metabolic changes was sought in
patients with PXE, with essentially normal findings. These
include normal levels of serum calcium (total and ionized),
phosphorus, and APase activity, as well as normal values for
24-hour quantitative urine analysis for calcium, phosphorus,
urea nitrogen, and creatinine (Neldner, 1988). Early meta-
bolic balance studies in a cohort of 12 PXE patients suggested
some degree of positive calcium balance, whereas additional
studies have suggested that high levels of calcium intake
during the childhood or adolescence correlates with the
severity of phenotypic presentation with PXE (Renie et al.,
1984; Neldner, 1988). More recently, preliminary studies
have suggested that treatment with aluminum hydroxide, an
oral phosphate binder, of patients with PXE can result in
significant clinical improvement of skin lesions, and no
deterioration of eye disease was seen in any of the six patients
examined at 1-year follow-up (Sherer et al., 2005). Collec-
tively, these findings suggest that abnormalities in calcium/
phosphate metabolism may contribute to the aberrant
mineralization process in PXE.
The pathomechanisms of PXE have also been previously
addressed in studies by incubating cultured fibroblasts from
the skin of patients with PXE and age-matched, unaffected
individuals in medium supplemented with normal human
serum, or serum from patients with PXE (Le Saux et al., 2006).
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Figure 5. ISH analysis of bone-associated gene expression in mouse vibrissae. Frozen sections of mouse muzzle skin were hybridized with Dig-labeled cRNA
antisense (upper panel) and sense (lower panel) probes for fetuin-A, MGP, type I collagen, APase, and Ank mRNA. Positive signal is indicated by red color.
Strong cell-associated signals were detected with antisense probes for (b vs g) MGP and (c vs h) type I collagen whereas weaker signals were observed with
antisense probes for (d vs i) APase and (e vs j) Ank. No signal was observed with (a) fetuin-A antisense probe or the (f) corresponding sense probe.
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The results indicated that in the presence of normal human
serum, PXE fibroblasts displayed increased synthesis of elastic
fibers in comparison with normal fibroblasts, but the fibers
were structurally normal. At the same time, PXE and normal
fibroblasts, when maintained in the presence of serum from
PXE patients, deposited abnormal aggregates of elastic fibers.
The authors concluded, therefore, that certain metabolites
present in PXE sera interfere with the normal assembly of
elastic fibers in vitro, but these authors were not able to
determine the effects of sera on the mineralization process in
their experimental system. Nevertheless, these data supported
the notion that PXE is a primary metabolic disorder with
secondary connective tissue manifestations.
The potential role of specific serum factors in tissue
mineralization in PXE was recently addressed by immunolo-
gic measurements of fetuin-A levels in sera from 110 German
patients with PXE, 53 of their unaffected first-degree family
members, and 80 healthy unrelated blood donor controls
(Hendig et al., 2006). The results showed that serum fetuin-A
concentrations in PXE patients were lower than in their
unaffected relatives or in controls: 0.5570.11 vs 0.7070.23
vs 0.8070.23 g/l (mean7SD), respectively (Po0.001). As
fetuin-A is a major systemic inhibitor of mineralization, the
implications of this latter finding are that the deficiency of
multidrug resistance-associated protein 6 in the liver may
cause alterations in the level of circulating metabolites, such
as fetuin-A, leading to progressive mineralization of con-
nective tissues in PXE.
In this study, we have examined the mineralization
process in further detail utilizing an animal model, the
Abcc6/mouse, that recapitulates genetic, histopathologic,
and ultrastructural features of PXE in humans (Klement et al.,
2005). This animal model allows careful comparisons of
affected (Abcc6/) mice with their heterozygous (Abcc6þ /)
or wild-type (Abcc6þ /þ ) littermates as controls. A consis-
tent finding in this mouse model is early-onset, progressive
mineralization of the connective tissue capsule surrounding
the vibrissae in the Abcc6/ mice, a feature that we have
suggested to serve as a biomarker of the overall mineraliza-
tion process. Validation of this mouse model in this study
allowed demonstration of up to B5-fold increase in
calciumphosphate content in the vibrissae, a notion which
correlates with histopathologic findings in these mice
(Figure 1). Our results were also able to show a small, yet
consistent, approximately 30% reduction in the serum fetuin-
A levels similar to those observed in the patients with PXE.
Further characterization of these mice demonstrated direct
association of fetuin-A, MGP, Ank, and APase activity with
the mineralization process affecting the connective tissue
capsules of vibrissae which are known to contain elastin and
type I collagen. Our results further demonstrated that fetuin-A
was synthesized in the liver, whereas ISH revealed no
expression in the connective tissue capsule of the vibrissae.
In contrast, clear signal for MGP, Ank, and APase expression
in the vibrissae was noted. Finally, we were able to
demonstrate that addition of recombinant fetuin-A to the in
vitro aortic smooth muscle cell culture system abolished the
mineralization process elicited by the addition of Pi.
Fetuin-A (also known as the a2-Heremans-Schmid glyco-
protein – the corresponding mouse gene symbol being Ahsg)
has been suggested to be an important inhibitor of calcifica-
tion acting on the systemic level (Scha¨fer et al., 2003). The
importance of fetuin-A in preventing aberrant mineralization
is demonstrated by development of a mouse model in which
the Ahsg gene was deleted by targeted ablation (Jahnen-
Dechent et al., 1997). The fetuin-A-deficient mice (Ahsg/)
developed severe calcification of various organs on a diet
rich in minerals and vitamin D and on normal diet when the
deficiency was combined with the DBA/2 genetic mouse
background with propensity for mineralization. Importantly,
this phenotype is not associated with changes in calcium and
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Figure 6. Recombinant mouse fetuin-A counteracts Pi-induced
mineralization in the presence of Abcc6/ mouse serum in aortic smooth
muscle cell (ASMC) culture. Human ASMC cultures were incubated in
DMEM in the presence of 10% serum obtained from Abcc6/ mice. After
having reachedB80% confluence, 2 mMPi was added and the cultures were
analyzed 14 days later for mineralization by (a) phase-contrast light
microscopy or by (b) assay of the calcium deposits associated with the cell
layer. The values for calcium deposition were corrected for the amount of
cell-associated protein (mg calcium/mg protein). Some cultures received
recombinant mouse fetuin-A (450, 900, or 1,350 ng per a total volume of
80ml of culture medium, i.e., 5.6, 11.3, or 16.9 ng/ml, respectively) at the time
of addition of Pi. Note that addition of þ Pi resulted in extensive
mineralization and profound calcium deposition, as compared to control
cultures (Pi). Addition of 900 or 1,350 ng of fetuin-A prevented this process.
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phosphate homeostasis, but results from decreased inhibitory
activity of fetuin-A-deficient extracellular fluid (serum) on
mineral formation (Scha¨fer et al., 2003). This genetic
evidence attesting to the role of fetuin-A as a systemic
inhibitor of mineralization has been complemented by
ultrastructural and biophysical data which demonstrate that
precipitation inhibition by fetuin-A is caused by transient
formation of soluble, colloidal spheres which contain fetuin-
A, calcium, and phosphate (Heiss et al., 2003). These soluble
‘‘calciprotein particles’’ become progressively more crystal-
line and insoluble in a time- and temperature-dependent
manner. Mutation analyses showed that the basic calcium
phosphate precipitation inhibition activity resides in the
amino-terminal cystatin-like domain, and computer-modeled
domain structures suggested that dense array of acidic
residues on the extended b-sheet of the cystatin-like domain
mediates inhibition of mineralization by fetuin-A. Concep-
tually, solubilization of fetuin-A containing calciprotein
particles may also provide a mechanistic framework to
remove insoluble calcium precipitates and transport them
from the site of mineralization.
Another bone-associated protein, which potentially serves
as an inhibitor of ectopic mineralization, is MGP, which is
expressed predominantly by vascular smooth muscle cells
and by chondrocytes. Transgenic mice lacking MGP die at
1–3 months after birth owing to mineralization of elastic
fibers and rupture of large elastic arteries, such as the aorta
(Luo et al., 1997; El-Maadawy et al., 2003). The presence of
MGP has been demonstrated in association with the
extracellular matrix, and specifically elastic laminae in
human arterial vessel wall (Spronk et al., 2001). In areas of
vascular calcification, colocalization of MGP and elastic
laminae is lost, and MGP is found in extracellular matrix at
the borders of vascular mineralization. These data suggest
close association between MGP and the mineralization
process. In fact, it has been suggested that undercarboxylated
MGP is biologically inactive and that poor vascular vitamin K
status may form a risk factor for vascular calcification
(Schurgers et al., 2001).
Another bone-associated protein participating in regula-
tion of mineralization is Ank, a cell-membrane associated
protein which transports intracellular inorganic pyropho-
sphate to the extracellular milieu (Wang et al., 2005). Ank
is expressed by hypertrophic and terminally differentiated
mineralizing growth plate chondrocytes, and its role in
controlling the mineralization process was deciphered,
in part, from the data obtained from investigation into
the genetic basis of murine progressive Ank. In this mouse
model, a mutation in the Ank gene resulted in a non-
functional protein, accompanied in homozygous mice by a
marked increase of intracellular inorganic pyrophosphate
concentration and a decrease of extracellular inorganic
pyrophosphate levels (Ryan 2001). As a consequence,
these mice showed severe joint mineralization and arthritis.
Collectively, these and related observations emphasized
the role of extracellular inorganic pyrophosphate in
suppressing pathologic deposition of calcium phosphate
complexes.
In this study, we have demonstrated the association of
fetuin-A, MGP, and Ank proteins and APase activity in the
mineralization process affecting connective tissues in
Abcc6/ mice. Among them, fetuin-A is clearly expressed
in the liver and subsequently transported in circulation to the
site of aberrant mineralization, colocalizing with the mineral
deposits in the connective tissue capsule of vibrissae. Thus,
fetuin-A represents a systemic factor and perturbations in its
serum and tissue levels may contribute to the mineralization
process. In contrast, MGP and Ank, as well as APase where
shown to be expressed locally in the vibrissae, thus
representing local control mechanisms of mineralization.
Collectively, the pathologic process leading to connective
tissue mineralization in PXE mouse model has both systemic
and local regulatory components.
As indicated above, fetuin-A-deficient mice on DBA/2
genetic background demonstrate extensive ectopic miner-
alization, the deposits consisting of calcium and phosphorous
complexes (Scha¨fer et al., 2003). The mineralization process
of fetuin-A-deficient mice, particularly those on DBA/2
background, appears to be more extensive and morphologi-
cally different from that noted in Abcc6/ mice, possibly
reflecting genetic variability of the mice and the presence of
potential modifier genes. Nevertheless, the inhibitory capa-
city of the mineralization process by serum from DBA/2-
Ahsgþ /þ wild-type mice was found to be IC50¼ 0.8%
serum, whereas the DBA/2-Ahsg/ littermates had an IC50
of 6.8%. Importantly, addition of recombinant fetuin-A into
the serum from Ahsg/ mice completely restored the
inhibitory capacity of the serum towards calcium and
phosphate precipitation (Scha¨fer et al., 2003). If the reduced
fetuin-A levels play indeed a pathomechanistic role in
ectopic mineralization of connective tissues in PXE, this
situation would raise the intriguing possibility that intrave-
nous protein therapy could halt, and even reverse, the
mineralization process which is the principal cause of
clinical manifestations in this currently intractable disease.
MATERIALS AND METHODS
Cell cultures and induction of calcification in vitro
Human aortic smooth muscle cells (Cascade BiologicsTM; Portland,
OR) were routinely cultured in DMEM normal growth medium. At
B80% confluence, the cells were switched to calcification-inducing
medium (DMEM supplemented with 2 mM Pi; Jono et al., 2000) or to
normal DMEM in the presence of either 10% fetal calf serum, or
10% mouse serum either from Abcc6þ /þ or Abcc6/ animals,
and continued to be cultured for up to 2 weeks. Recombinant mouse
fetuin-A (R&D Systems, Minneapolis, MN) was added to some
cultures. The medium was changed every 3 days. The first day of
culture in calcification-inducing medium was defined as day 0.
Quantification of calcium and calcium  phosphate deposition
At day 14 of cell culture, the media were removed and the cell layers
were decalcified with 0.6 N HCl for 24 hours at room temperature.
The calcium content of the HCl supernatants was determined
colorimetrically by the o-cresolphthalein complexone method
(Calcium kit; Sigma, St Louis, MO). After decalcification, the cells
were rinsed three times with phosphate-buffered saline and
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solubilized with 0.1 N NaOH/0.1% SDS at room temperature. The
protein content was measured with Protein Assay Kit (Bio-Rad,
Hercules, CA), and the calcium content of the cell layer was
normalized to protein content.
To quantify the calcium deposition in mouse vibrissae, the
muzzle skin, which contains the vibrissae, was harvested and
decalcified with 0.15 N HCl for 48 hours. The calcium content was
measured as above and the phosphate content was determined with
Malachite Green Phosphate Assay kit (BioAssay Systems, Hayward,
CA). The values for calcium and phosphate were normalized to
tissue weight.
Histopathology with Alizarin Red stain and APase activity
analysis
Tissue sections were deparaffinized, incubated with 2% aqueous
solution of Alizarin Red for 3 minutes, rinsed with distilled water,
counterstained with 1% aqueous fast green, and then dehydrated
through an ascending series of graded concentrations of alcohol.
After clearance in xylene, slides were mounted with Permount
(Fisher, Fair Lawn, NJ).
Frozen sections with vibrissae from Abcc6/ mice were
incubated with 5-bromo-4-chloro-3-indoylphosphate/p-nitro blue
tetrazolium chloride (BCIP/NBT; Chemicon, Temecula, CA) for
10–15 minutes at room temperature and then rinsed with distilled
water. After counterstaining with hematoxylin, the sections were
mounted with Permount (Fisher).
ELISA
Fetuin-A levels in mouse serum were determined by an indirect
ELISA. Ninety-six-well immunoplates (Nalge Nunc International,
Rochester, NY) were coated overnight at 41C with a monoclonal
anti-mouse fetuin-A antibody (R&D Systems), 50 ng/well. The wells
were washed three times with phosphate-buffered saline/0.05%
Tween and then blocked with 5% BSA at room temperature for
2 hours. A standard curve was constructed by adding recombinant
mouse fetuin-A in concentrations up to 50 ng/ml. For assay of mouse
serum levels of fetuin-A, serum in 1:5,000 dilution was added. After
appropriate incubations and washings, biotinylated goat anti-mouse
fetuin-A antibody, 1:1,000 dilution was added, followed by
incubation for 1 hour at room temperature and washings. Horse-
radish peroxidase-avidin (Zymed, South San Francisco, CA) was then
added, incubated for 1 hour, washed five times with phosphate-
buffered saline/0.05% Tween, and followed by color development
using tetramethylbenzidine solution (Pierce, Rockford, IL) and 2 M
H2S04; the optical density was read at 450 nm.
Immunofluorescence for bone-associated proteins
Unstained slides of 5–6mm tissue sections were deparaffinized in
xylene and rehydrated in a descending series of graded concentra-
tions of alcohol. After washing in 1 phosphate-buffered saline,
sections were blocked by 3% BSA for 1 hour at room temperature,
and then incubated with the primary antibody at appropriate
dilutions for 1 hour. The secondary antibody, Texas Red or FITC-
conjugated anti-goat IgG at 1:250 dilution, was applied for 1 hour.
The primary antibodies utilized were: anti-type I collagen (1:100,
Rockland Immunochemicals Inc., Gilbertsville, PA), anti-fetuin-A
(1:200, R&D), anti-MGP (1:16, TransGenic, Kumamoto, Japan), and
anti-Ank (1:100, Jackson Immuno Research Laboratories, West
Grove, PA). Staining without the primary antibody served as a
negative control and was carried out for each section. Vibrissae from
both Abcc6/ and Abcc6þ /þ mice were examined.
Western blot
Proteins were isolated from Abcc6/ or Abcc6þ /þ mouse liver
and subjected to SDS/PAGE (8% gel) in the presence of reducing
agent. Protein was electrotransferred to polyvinylidene fluoride
membrane, and nonspecific binding sites on the membrane were
blocked by incubation in 5% milk for 1 hour at room temperature.
The blot was incubated with anti-fetuin-A antibody at 1:1,000
dilution overnight at 41C, and then incubated with horseradish
peroxidase-labeled anti-goat secondary antibody at 1:80,000 dilu-
tion for 1 hour at room temperature. After three 10 minutes washings,
the signal was determined with ECL PlusTM Western Blotting Reagent
Pack (Amersham Biosciences, Piscataway, NJ).
Multiplex RT-PCR
Total RNA was extracted from Abcc6/ or Abcc6þ /þ mouse
muzzle biopsies containing vibrissae as well as from mouse liver
with a RNeasy Mini Kit (Qiagen, Valencia, CA) by applying the on-
column DNase treatment according to the manufacturer’s instruc-
tions. The amount and quality of the RNA were verified by
measuring the absorbance at 260/280 nm. Random-primed reverse
transcription of RNA was performed with the SuperScript First-Strand
Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA), using 1mg of
RNA for each reaction. The QuantumRNA 18S Internal Standards kit
(Ambion, Austin, TX) was used to simultaneously amplify the
transcript of the gene of interest and the 18S rRNA transcript that
was used as an internal standard. To determine the number of cycles
to use in the PCR reaction, a cycle number was chosen in the linear
portion of the amplification process. To have both the target-of-
interest and the 18S control target to amplify so as to yield similar
quantities of the product, an optimal ratio of 18S to Competimers
was chosen without affecting the performance of the target-of-
interest template in the multiplex PCR. The primer sequences and
the PCR conditions are available from the corresponding author
upon request. PCR products were electrophoresed on 3% agarose
gels containing ethidium bromide and visualized by UV-induced
fluorescence. The densities of target gene and 18S PCR products
were determined by scanning densitometry of computer images
using Scion Imaging Software (Scion Corporation, Frederick, MD).
Microarray analysis
The fetuin-A mRNA levels in the liver of Abcc6/ mice in
comparison to their wild-type counterparts (Abcc6þ /þ ) were also
derived from microarray data. In brief, total RNA in liver was
extracted using a RNeasy Mini kit (Qiagen, Valencia, CA) from three
individual Abcc6/ mice and three wild-type controls. Labeled
targets from 10mg of total RNA were used for hybridization on
custom made mRNA microarray chips containing 420,000 genes
(Microarray Core Facility, Kimmel Cancer Center, Thomas Jefferson
University). Patterns of hybridization were detected with a Perkin-
Elmer ScanArray XL5K Scanner.
In situ hybridization
ISH was carried out to detect the mRNAs encoding by the following
bone-associated genes: fetuin-A (NM_013465), MGP (BC079478),
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APase (X13409), type I collagen (NM_007742) and Ank (AF274752).
To obtain desired probes, RT-PCR products of the bone-associated
genes were amplified using primers that were designed on the basis
of available sequence information using Primer 3 program (White-
head Institute for Biomedical Research). The PCR products, after
appropriate restriction enzyme digestions, were ligated to pSPT18 or
pSPT19 vector (Roche, Indianapolis, IN). Antisense and sense
riboprobes labeled with Dig were prepared by using a Dig RNA
labeling kit (Roche) according to the manufacturer’s instructions.
Probes were stored in diethylpyrocarbonate-treated H2O at 801C.
Sections (9mm) were cut from cryopreserved tissues and then
mounted onto 3-aminopropyltriethoxysilane-coated microscope
slides. Tissue sections were fixed in 4% paraformaldehyde for
1 hour at room temperature and digested for 25 minutes with
proteinase K (10 mg/ml). Tissue sections were then rinsed in
diethylpyrocarbonate-H2O, acetylated in 0.25% acetic anhydride
in 0.1 M triethanolamine (pH 8.0), and dehydrated through a series of
graded concentrations of alcohol. One hundred microliters of
hybridization mixture containing the probe (200 ng/ml) was spotted
on each slide, sealed under a coverslip, and incubated for
B15–18 hours on a slide warmer preheated at 561C. Slides were
rinsed in 4 standard saline citrate at room temperature for
30 minutes and the coverslips were then gently removed. After
additional rinses in 4 standard saline citrate, tissue sections were
digested with RNase A (20 mg/ml, 371C, 30 minutes), rinsed in
decreasing concentrations of standard saline citrate (2 , 1 ,
0.5 ), and then washed in 0.1 standard saline citrate for
30 minutes at 601C. Tissue sections were rinsed in phosphate-
buffered saline for 5 minutes and immediately processed for
immunohistochemistry. After blocking with 20% rabbit IgG fraction
in blocking buffer, the labeled probes were detected using horse-
radish peroxidase-conjugated anti-Dig antibody, the signal was
amplified by consecutively incubating the sections with biotinylated
anti-horseradish peroxidase antibody, biotinyl-tyramide, and APase-
conjugated anti-biotin antibody. The signal was detected by
incubation with Fast Red TR/Naphthol (FastTM, Sigma Chemical Co,
St Louis, MO), prepared according to the manufacturer’s instruc-
tions. The sections were counterstained with hematoxylin and
mounted with Glycergels mounting medium (DAKO, Carpinteria,
CA).
Statistical analysis
Statistical differences between the means were calculated by the
Student’s two-tailed t-test.
Animal care
These studies were approved by the Institutional Animal Care and
Use Committee by Thomas Jefferson University and they are in
accordance with the animal welfare guidelines of the National
Institutes of Health and Association for Assessment and Accredita-
tion of Laboratory Animal Care.
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